Skip to content

Clinical trials

Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Clear all

606 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200023
200114
200220
200318
200419
200521
200622
200721
200813
200928
201026
201126
201225
201316
201421
201524
201611
201725
201818
201919
202015
202117
202217
202311
202425
202521
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed331
Terminated86
Recruiting65
Unknown status52
Active, not recruiting34
Withdrawn22
Not yet recruiting10
Suspended3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center49
M.D. Anderson Cancer Center41
National Cancer Institute (NCI)26
Masonic Cancer Center, University of Minnesota21
St. Jude Children's Research Hospital18
Memorial Sloan Kettering Cancer Center17
City of Hope Medical Center16
Case Comprehensive Cancer Center12
Gruppo Italiano Malattie EMatologiche dell'Adulto12
National Heart, Lung, and Blood Institute (NHLBI)10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma606
Leukemia, Myeloid, Acute253
Lymphoma, Non-Hodgkin193
Leukemia, Lymphocytic, Chronic, B-Cell182
Leukemia181
Myelodysplastic Syndromes180
Burkitt Lymphoma177
Hodgkin Disease149
Lymphoma145
Lymphoma, Follicular135

Trials

Showing 76 to 100 of 606. Each trial links to its page on Pharma Observatory.

506 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.